Literature DB >> 11521967

Studies of phospholipid metabolism, proliferation, and secretion of stably transfected insulinoma cells that overexpress group VIA phospholipase A2.

Z Ma1, A Bohrer, M Wohltmann, S Ramanadham, F F Hsu, J Turk.   

Abstract

A cytosolic 84 kDa Group VIA phospholipase A2 (iPLA2beta) that does not require Ca2+ for catalysis was cloned from Chinese hamster ovary (CHO) cells, murine P388D1 cells, pancreatic islet beta-cells, and other sources. Proposed iPLA2beta functions include participation in phosphatidylcholine (PC) homeostasis by degrading excess PC generated in CHO cells that overexpress CTP:phosphocholine cytidylyltransferase (CT), which catalyzes the rate-limiting step in PC biosynthesis; participation in biosynthesis of arachidonate-containing PC species in P388D1 cells by generating lysophosphatidylcholine (LPC) acceptors for arachidonate incorporation; and participation in signaling events in insulin secretion from islet beta-cells. To further examine iPLA2beta functions in beta-cells, we prepared stably transfected INS-1 insulinoma cell lines that overexpress iPLA2beta activity eightfold compared to parental INS-1 cells or to INS-1 cells transfected with an empty retroviral vector that did not contain iPLA2beta cDNA. The iPLA2beta-overexpressing cells exhibit a twofold increase in CT activity compared to parental cells but little change in rates of [3H]choline incorporation into or disappearance from PC. Electrospray ionization (ESI) tandem mass spectrometric measurements indicate that iPLA2beta-overexpressing cells have 1.5-fold higher LPC levels than parental INS-1 cells but do not exhibit increased rates of [3H]arachidonate incorporation into phospholipids, and incorporation is unaffected by a bromoenol lactone (BEL) suicide substrate inhibitor of iPLA2beta. The rate of appearance of arachidonate-containing phosphatidylethanolamine species visualized by ESI mass spectrometry is also similar in iPLA2beta-overexpressing and parental INS-1 cells incubated with supplemental arachidonic acid, and this process is unaffected by BEL. Compared to parental INS-1 cells, iPLA2beta-overexpressing cells proliferate more rapidly and exhibit amplified insulin secretory responses to a protein kinase C-activating phorbol ester, glucose, and a cAMP analog. These findings suggest that iPLA2beta plays a signaling role in beta-cells that differs from housekeeping functions in PC biosynthesis and degradation in P388D1 and CHO cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521967     DOI: 10.1007/s11745-001-0774-9

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  93 in total

Review 1.  Phospholipase A2 and its potential regulation of islet function.

Authors:  E Simonsson; B Ahrén
Journal:  Int J Pancreatol       Date:  2000-02

2.  Role of Ca(2+)-independent phospholipase A(2) in the regulation of inducible nitric oxide synthase in cardiac myocytes.

Authors:  E Isenović; M C LaPointe
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

3.  Regulation of insulin secretion from novel engineered insulinoma cell lines.

Authors:  H E Hohmeier; H BeltrandelRio; S A Clark; R Henkel-Rieger; K Normington; C B Newgard
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

4.  Choline turnover in phosphatidylcholine of pancreatic islets. Implications for CDP-choline pathway.

Authors:  J M Hoffman; S G Laychock
Journal:  Diabetes       Date:  1988-11       Impact factor: 9.461

5.  Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: comparison to other tissues and implications for membrane fusion in insulin exocytosis.

Authors:  S Ramanadham; F F Hsu; A Bohrer; W Nowatzke; Z Ma; J Turk
Journal:  Biochemistry       Date:  1998-03-31       Impact factor: 3.162

6.  Mass spectrometric identification and quantitation of arachidonate-containing phospholipids in pancreatic islets: prominence of plasmenylethanolamine molecular species.

Authors:  S Ramanadham; A Bohrer; M Mueller; P Jett; R W Gross; J Turk
Journal:  Biochemistry       Date:  1993-05-25       Impact factor: 3.162

7.  Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in beta-cell cytosolic calcium ion concentration.

Authors:  S Ramanadham; R W Gross; X Han; J Turk
Journal:  Biochemistry       Date:  1993-01-12       Impact factor: 3.162

8.  Rat and human pancreatic islet cells contain a calcium ion independent phospholipase A2 activity selective for hydrolysis of arachidonate which is stimulated by adenosine triphosphate and is specifically localized to islet beta-cells.

Authors:  R W Gross; S Ramanadham; K K Kruszka; X Han; J Turk
Journal:  Biochemistry       Date:  1993-01-12       Impact factor: 3.162

9.  Fatty acid incorporation into phospholipids of isolated pancreatic islets of the rat. Relationship to insulin release.

Authors:  S G Laychock
Journal:  Diabetes       Date:  1983-01       Impact factor: 9.461

10.  Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels.

Authors:  T C Becker; H BeltrandelRio; R J Noel; J H Johnson; C B Newgard
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

View more
  24 in total

Review 1.  Islet complex lipids: involvement in the actions of group VIA calcium-independent phospholipase A(2) in beta-cells.

Authors:  Sasanka Ramanadham; Haowei Song; Shunzhong Bao; Fong-Fu Hsu; Sheng Zhang; Zhongmin Ma; Chun Jin; John Turk
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

2.  Characterization of N-terminal processing of group VIA phospholipase A2 and of potential cleavage sites of amyloid precursor protein constructs by automated identification of signature peptides in LC/MS/MS analyses of proteolytic digests.

Authors:  Haowei Song; Silva Hecimovic; Alison Goate; Fong-Fu Hsu; Shunzhong Bao; Ilan Vidavsky; Sasanka Ramanadham; John Turk
Journal:  J Am Soc Mass Spectrom       Date:  2004-12       Impact factor: 3.109

3.  Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine.

Authors:  Konstantin Seleznev; Chunying Zhao; Xu Hannah Zhang; Keying Song; Zhongmin Alex Ma
Journal:  J Biol Chem       Date:  2006-05-25       Impact factor: 5.157

4.  Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.

Authors:  Daren Stephens; Efrosini Barbayianni; Violetta Constantinou-Kokotou; Anna Peristeraki; David A Six; Jennifer Cooper; Richard Harkewicz; Raymond A Deems; Edward A Dennis; George Kokotos
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

5.  Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.

Authors:  George Kokotos; Yuan-Hao Hsu; John E Burke; Constantinos Baskakis; Christoforos G Kokotos; Victoria Magrioti; Edward A Dennis
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

6.  Modulation of the pancreatic islet beta-cell-delayed rectifier potassium channel Kv2.1 by the polyunsaturated fatty acid arachidonate.

Authors:  David A Jacobson; Christopher R Weber; Shunzhong Bao; John Turk; Louis H Philipson
Journal:  J Biol Chem       Date:  2006-12-29       Impact factor: 5.157

Review 7.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

8.  Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility.

Authors:  Shunzhong Bao; David J Miller; Zhongmin Ma; Mary Wohltmann; Grace Eng; Sasanka Ramanadham; Kelle Moley; John Turk
Journal:  J Biol Chem       Date:  2004-07-12       Impact factor: 5.157

9.  Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance.

Authors:  Keying Song; Xu Zhang; Chunying Zhao; Natasha T Ang; Zhongmin Alex Ma
Journal:  Mol Endocrinol       Date:  2004-10-07

10.  Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase.

Authors:  Xu Hannah Zhang; Chunying Zhao; Konstantin Seleznev; Keying Song; James J Manfredi; Zhongmin Alex Ma
Journal:  J Cell Sci       Date:  2006-02-21       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.